Literature DB >> 24030695

Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels.

Jian-Bin Su1, Tong Chen, Feng Xu, Xue-Qin Wang, Jin-Feng Chen, Gang Wu, Yan Jin, Xiao-Hua Wang.   

Abstract

Subjects with normal glucose regulation (NGR), whose 1-h postload plasma glucose is ≥8.6 mmol/L (155 mg/dL, NGR 1 h ≥ 8.6) during 75-g oral glucose tolerance test (OGTT), have an increased risk of type 2 diabetes and subclinical organ damage. And, the deficiency in islet β cell function is responsible for glycemic disorders. The purpose of this study is to investigate glycemic variability in NGR subjects with elevated 1-h postload plasma glucose levels and its association with islet β cell function. The 29 NGR subjects with 1-h postload plasma glucose ≥8.6 mmol/L (NGR 1 h ≥ 8.6) and 29 age- and sex-matched NGR subjects with 1-h postload plasma glucose <8.6 mmol/L (NGR 1 h < 8.6) were recruited in the study. Insulin sensitivity (Matsuda index, ISI), insulin secretion (insulinogenic index ΔI30/ΔG30), and integrated β cell function measured by the oral disposition index (ΔI30/ΔG30 multiplied by the ISI) were derived from OGTT. All subjects were monitored using the continuous glucose monitoring system for consecutive 72 h. The multiple parameters of glycemic variability included the standard deviation of blood glucose (SDBG), mean blood glucose (MBG), mean of daily differences (MODD), and mean amplitude of glycemic excursions (MAGE). MAGE is considered as a gold standard of glycemic variability. Glycemic variability parameters SDBG, MBG, MODD, and MAGE in NGR 1 h ≥ 8.6 group were higher than those in NGR 1 h < 8.6 group (p < 0.05), and oral disposition index in NGR 1 h ≥ 8.6 group was lower than that in NGR 1 h < 8.6 group (p < 0.05). SDBG, MBG, MODD, MAGE, and 1-h postload plasma glucose all negatively associated with oral disposition index in the separate group (p < 0.05) and in the whole subjects (p < 0.05). After multivariate regression analysis, oral disposition index was the strongest independent contributor to MAGE and 1-h postload plasma glucose in the separate group (p < 0.05) and in the whole subjects (p < 0.05). It is concluded that NGR 1 h ≥ 8.6 group had higher glycemic variability and lower oral disposition index, compared with NGR 1 h < 8.6 group. Increased glycemic variability parameters and elevated 1-h postload plasma glucose consistently associated with declined oral disposition index in subjects from NGR 1 h < 8.6 to NGR 1 h ≥ 8.6 group.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030695     DOI: 10.1007/s12020-013-0047-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  43 in total

1.  Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?

Authors:  Louis Monnier; Claude Colette; David R Owens
Journal:  J Diabetes Sci Technol       Date:  2008-11

2.  The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go.

Authors:  A Lapolla; A Mosca; D Fedele
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-06-08       Impact factor: 4.222

Review 3.  The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.

Authors:  R E Pratley; C Weyer
Journal:  Diabetologia       Date:  2001-08       Impact factor: 10.122

4.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

Review 5.  Glycemic risk factors of diabetic vascular complications: the role of glycemic variability.

Authors:  Francesco Zaccardi; Dario Pitocco; Giovanni Ghirlanda
Journal:  Diabetes Metab Res Rev       Date:  2009-03       Impact factor: 4.876

6.  Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.

Authors:  Andreas Festa; Ken Williams; Anthony J G Hanley; Steven M Haffner
Journal:  Diabetes       Date:  2008-03-10       Impact factor: 9.461

7.  Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.

Authors:  Sri Venkata Madhu; Subrat Kumar Muduli; Rajnish Avasthi
Journal:  Diabetes Technol Ther       Date:  2013-04-30       Impact factor: 6.118

8.  Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.

Authors:  Ravi Retnakaran; Sandy Shen; Anthony J Hanley; Vladimir Vuksan; Jill K Hamilton; Bernard Zinman
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002

Review 9.  Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2012-11-07       Impact factor: 3.633

10.  Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

Authors:  Kristina M Utzschneider; Ronald L Prigeon; Mirjam V Faulenbach; Jenny Tong; Darcy B Carr; Edward J Boyko; Donna L Leonetti; Marguerite J McNeely; Wilfred Y Fujimoto; Steven E Kahn
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 19.112

View more
  5 in total

1.  High-normal 2 h glucose is associated with defects of insulin secretion and predispose to diabetes in Chinese adults.

Authors:  Ziwei Lin; Jian Zhou; Xiaowen Li; Lige Song; Xuhong Hou; Junling Tang; Chen Wang; Weiping Jia
Journal:  Endocrine       Date:  2014-04-08       Impact factor: 3.633

2.  Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study.

Authors:  Brenda Dorcely; Eliud Sifonte; Collin Popp; Anjana Divakaran; Karin Katz; Sarah Musleh; Ram Jagannathan; Margaret Curran; Mary Ann Sevick; José O Aleman; Ira J Goldberg; Michael Bergman
Journal:  Endocrine       Date:  2022-06-21       Impact factor: 3.925

3.  Small changes in glucose variability induced by low and high glycemic index diets are not associated with changes in β-cell function in adults with pre-diabetes.

Authors:  Kristina M Utzschneider; Tonya N Johnson; Kara L Breymeyer; Lisa Bettcher; Daniel Raftery; Katherine M Newton; Marian L Neuhouser
Journal:  J Diabetes Complications       Date:  2020-04-18       Impact factor: 2.852

4.  Glycemic variability in normal glucose tolerance women with the previous gestational diabetes mellitus.

Authors:  Yong-Mei Wang; Li-Hua Zhao; Jian-Bin Su; Hai-Feng Qiao; Xiao-Hua Wang; Feng Xu; Tong Chen; Jin-Feng Chen; Gang Wu; Xue-Qin Wang
Journal:  Diabetol Metab Syndr       Date:  2015-09-24       Impact factor: 3.320

5.  Glycemic deviation index: a novel method of integrating glycemic numerical value and variability.

Authors:  Yizhou Zou; Wanli Wang; Dongmei Zheng; Xu Hou
Journal:  BMC Endocr Disord       Date:  2021-03-19       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.